80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC)

• Matthew Loya,
• Homer Adams,
• Omar Jabado,
• Patrick Franken,
• Nora Pencheva,
• Mark Fereshteh,
• Li Fan,
• Anantharaman Muthuswamy,
• Angelo Harris,
• Susan Sun,
• Gabrielle Suppa

Affiliations

Matthew Loya

1Genmab, Princeton, NJ, USA

Homer Adams

Aff565 Janssen Pharmaceutical R&D Spring House PA USA

Omar Jabado

1 Translational Bioinformatics, Bristol-Myers Squibb, Princeton, New Jersey, USA

Patrick Franken

Genmab, Princeton, NJ, USA

Nora Pencheva

3Genmab, Utrecht, Netherlands

Mark Fereshteh

2Genmab A/S, Utrecht, Netherlands

Li Fan

Genmab, Princeton, NJ, USA

Anantharaman Muthuswamy

Genmab, Plainsboro, NJ, USA

Angelo Harris

Genmab, Princeton, NJ, USA

Susan Sun

1Genmab, Princeton, NJ, USA

Gabrielle Suppa

1Genmab US, Inc., Princeton, NJ, USA